ToolGen Incorporated Logo

ToolGen Incorporated

Biotechnology company developing genome editing for therapeutics and agriculture.

199800 | KO

Overview

Corporate Details

ISIN(s):
KR7199800004
LEI:
Country:
South Korea
Address:
서울특별시 강서구 마곡중앙로 172 바이오이노베이션파크,8층, 강서구

Description

ToolGen Incorporated is a biotechnology company specializing in the development and application of genome editing technology. Founded in 1999, the company has developed multiple generations of gene editing tools, including Zinc Finger Nucleases (ZFNs), Transcription Activator-Like Effector Nucleases (TALENs), and the CRISPR-Cas9 system. ToolGen is a key patent holder for CRISPR-Cas9 technology, being the first to file a patent for its application in eukaryotic cells. The company's business model focuses on developing therapeutics and agricultural products, as well as monetizing its intellectual property through licensing and collaborations. Its primary mission is to translate genetic knowledge into transformative products for biomedicine and agriculture.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2021-12-24 00:00
[기재정정]주식매수선택권부여에관한신고
Korean 29.6 KB
2021-12-16 00:00
신규시설투자등
Korean 8.7 KB
2021-12-15 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2021-12-15 00:00
주식등의대량보유상황보고서(약식)
Korean 53.9 KB
2021-12-10 00:00
기타경영사항(특허권취득)(자율공시)(인위적으로 조작된 조작면역세포)
Korean 6.5 KB
2021-12-06 00:00
증권발행결과(자율공시)(일반공모 유상증자)
Korean 6.0 KB
2021-12-06 00:00
상장폐지결정(코스닥시장 이전상장)
Korean 8.2 KB
2021-12-06 00:00
증권발행실적보고서
Korean 111.9 KB
2021-12-03 00:00
유상증자또는주식관련사채등의청약결과(자율공시)(일반공모 유상증자)
Korean 8.6 KB
2021-11-30 00:00
유상증자최종발행가액확정(일반공모)
Korean 5.4 KB
2021-11-30 00:00
[발행조건확정]증권신고서(지분증권)
Korean 608.7 KB
2021-11-30 00:00
[기재정정]주요사항보고서(유상증자결정)
Korean 222.1 KB
2021-11-30 00:00
[기재정정]투자설명서
Korean 4.0 MB
2021-11-25 00:00
투자설명서
Korean 3.4 MB
2021-11-22 00:00
기업설명회(IR)개최결과
Korean 6.6 KB

Automate Your Workflow. Get a real-time feed of all ToolGen Incorporated filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ToolGen Incorporated

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ToolGen Incorporated via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.